Bayard L. Powell, MD
- Professor, Hematology and Oncology

Bayard L. Powell, MD
Research Interests
- Clinical Research in Acute Leukemia
- Chronic Leukemia
- Myelodysplastic Syndrome
- Education
- BSE, Duke University, 1976
- MD, University of North Carolina at Chapel Hill School of Medicine, 1980
- Residency
- Wake Forest Baptist Medical Center, 1983
- Board Certifications
- American Board of Internal Medicine, Internal Medicine
- American Board of Internal Medicine, Medical Oncology
- Memberships
- American College of Physicians
- Cancer and Acute Leukemia Group B.
- American Society of Hematology
- American Society of Clinical Oncology
- Association of Med Schl Professors of Psycholgy
- Positions
- Section Chief, Hematology and Oncology
- Medical Director for Medical Oncology, Hematology and Oncology
- Professor, Hematology and Oncology
- Departments and Affiliations
- Hematology and Oncology
- Comprehensive Cancer Center
Research
- Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720. Baer MR, George SL, Sanford BL, Mrózek K, Kolitz JE, Moore JO, Stone RM, Powell BL, Caligiuri MA, Bloomfield CD, Larson RA. Leukemia. 2011 May; 25(5):800-7.
- Exercise for older adult inpatients with acute myelogenous leukemia: A pilot study. Klepin HD, Danhauer SC, Tooze JA, Stott K, Daley K, Vishnevsky T, Powell BL, Mihalko SL. J Geriatr Oncol. 2011 Jan; 2(1):11-17.
- Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. Schwind S, Maharry K, Radmacher MD, Mrózek K, Holland KB, Margeson D, Whitman SP, Hickey C, Becker H, Metzeler KH, Paschka P, Baldus CD, Liu S, Garzon R, Powell BL, Kolitz JE, Carroll AJ, Caligiuri MA, Larson RA, Marcucci G, Bloomfield CD. J. Clin. Oncol. 2010 Dec; 28(36):5257-64.
- Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia. Ranganathan A, Powell BL. Clin Lymphoma Myeloma Leuk. 2010 Oct; 10 Suppl 3:S135-8.
- Treatment of patients with acute promyelocytic leukemia: a consensus statement on risk-adapted approaches to therapy. Tallman M, Douer D, Gore S, Powell BL, Ravandi F, Rowe J, Ranganathan A, Sanz MA. Clin Lymphoma Myeloma Leuk. 2010 Oct; 10 Suppl 3:S122-6.